Neoadjuvant chemoradiation for patients with resectable locally advanced oral cavity squamous cell carcinoma: Results of the prospective INVERT clinical trial
Neoadjuvant CRT is feasible and safe, achieving high pCR rates in LAOCSCC.pCR was associated with improved outcomes.
Authors
- Christian Issing (ORCID: https://orcid.org/0000-0002-9433-8306)
- Ria Winkelmann (ORCID: https://orcid.org/0000-0002-3772-231X)
- Claus Michael Rödel (ORCID: https://orcid.org/0009-0006-1777-2359)
- A Kristen
- Andreas Weigert (ORCID: https://orcid.org/0000-0002-7529-1952)
- Franz Rödel (ORCID: https://orcid.org/0000-0001-6057-1022)
- Maximilian Fleischmann
- Panagiotis Balermpas (ORCID: https://orcid.org/0000-0001-5261-6446)
- Markus Diefenhardt (ORCID: https://orcid.org/0000-0002-9042-9729)
- Iris Burck (ORCID: https://orcid.org/0000-0003-1349-4807)
- Jens von der Grün (ORCID: https://orcid.org/0000-0002-9371-7814)
- Christian Brandts (ORCID: https://orcid.org/0000-0003-1732-2535)
- Shahram Ghanaati (ORCID: https://orcid.org/0000-0002-7897-0854)
- Daniel Martín (ORCID: https://orcid.org/0000-0001-8678-3023)
- Philipp Thönissen
Institutions
- Goethe University Frankfurt (DE)
- Heidelberg University (DE)
- Senckenberg Research Institute and Natural History Museum Frankfurt/M (DE)
- University Hospital of Zurich (CH)
- Frankfurt Cancer Institute (DE)
Publication Details
- Journal
- Oral Oncology
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1016/j.oraloncology.2025.107252
- Citations
- 4
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 7.39